Clinical Trial Registry

Home Research & Innovation Clinical Trial Registry

AMERICAS

Study Name

Institution/Hospital

Principal Investigator

Further Information

A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR-Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma

Memorial Sloan Kettering Cancer Center,

New York, USA.

Dr. William Jarnagin.

Please see Clinical Trial Information here

EUROPE, AFRICA AND MIDDLE EAST

Study Name

Institution/Hospital

Principal Investigator

Further Information

NELMAS: phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best support care in patients after resection of neuroendocrine liver metastases

Imperial College London

London, UK.

Professor Andrea Frilling.

Please see Clinical Trial Information here

Reappraisal of the impact of resection margin on outcomes after hepatectomy and preiopeactive treatment for alveolar echinococcosis: a single center experience.

Chu Besancon

Besancon, France.

Mr Antoine Notte.

Please see Clinical Trial Information here

If you would like to add details of an HPB Clinical Trial to the IHPBA registry please complete the form below.

Submit clinical trial details here

All submissions will be reviewed by the IHPBA Research Committee before being added to the website.